StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.42+0.03 (+2.16%)

Close on Nov 16, 2026Market cap $36.07MP/E –Yield –

Serina Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Serina Therapeutics's total assets was $25.81M at Jun 30, 2026. For fiscal 2025 it was $6.95M, up 3.4% from the year before. The highest annual figure on record is $10.67M in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.95M+3.4%
FY2024Dec 31, 2024$6.72M-25.0%
FY2023Dec 31, 2023$8.97M+176.7%
FY2022Dec 31, 2022$3.24M+2.8%
FY2021Dec 31, 2021$3.15M-19.6%
FY2020Dec 31, 2020$3.93M-47.3%
FY2019Dec 31, 2019$7.44M-30.3%
FY2018Dec 31, 2018$10.67M+10.8%
FY2017Dec 31, 2017$9.63M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$25.81M+188.7%
Q1 FY2026Mar 31, 2026$27.30M+305.6%
Q4 FY2025Dec 31, 2025$6.95M+3.4%
Q3 FY2025Sep 30, 2025$12.41M+67.0%
Q2 FY2025Jun 30, 2025$8.94M-16.5%
Q1 FY2025Mar 31, 2025$6.73M-38.0%
Q4 FY2024Dec 31, 2024$6.72M-25.0%
Q3 FY2024Sep 30, 2024$7.44M-39.1%
Q2 FY2024Jun 30, 2024$10.71M-12.8%
Q1 FY2024Mar 31, 2024$10.86M-13.4%
Q4 FY2023Dec 31, 2023$8.97M+176.7%
Q3 FY2023Sep 30, 2023$12.21M+508.1%
Q2 FY2023Jun 30, 2023$12.28M+376.0%
Q1 FY2023Mar 31, 2023$12.53M+361.4%
Q4 FY2022Dec 31, 2022$3.24M+2.8%
Q3 FY2022Sep 30, 2022$2.01M-17.3%
Q2 FY2022Jun 30, 2022$2.58M+1.5%
Q1 FY2022Mar 31, 2022$2.72M-14.1%
Q4 FY2021Dec 31, 2021$3.15M-19.6%
Q3 FY2021Sep 30, 2021$2.43M-42.3%
Q2 FY2021Jun 30, 2021$2.54M-46.6%
Q1 FY2021Mar 31, 2021$3.16M-37.9%
Q4 FY2020Dec 31, 2020$3.93M-47.3%
Q3 FY2020Sep 30, 2020$4.20M-48.6%
Q2 FY2020Jun 30, 2020$4.76M-53.6%
Q1 FY2020Mar 31, 2020$5.09M-58.7%
Q4 FY2019Dec 31, 2019$7.44M-30.3%
Q3 FY2019Sep 30, 2019$8.18M-15.0%
Q2 FY2019Jun 30, 2019$10.26M–
Q1 FY2019Mar 31, 2019$12.32M–
Q4 FY2018Dec 31, 2018$10.67M–
Q4 FY2017Dec 31, 2017$9.63M–

More Serina Therapeutics figures

See a number that looks wrong?